AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DIOSMIN
7 registrations across 3 African markets— 6 active
Markets with DIOSMIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Dr. Meyer’s Pilex Tablet** Tablet | 🇳🇬Nigeria | Farmex Meyer Limited | active | Jul 2029 |
| VENEX - 500 Tablets (Sugar coated) | 🇿🇲Zambia | ELDER PROJECT LIMITED | active | May 2029 |
| PHLEBODIA | 🇬🇭Ghana | LABORATOIRE INNOTECH INTERNATIONAL | active | Sept 2026 |
| PHLEBODIA | 🇬🇭Ghana | LABORATOIRE INNOTECH INTERNATIONAL | active | Sept 2026 |
| PHLEBODIA | 🇬🇭Ghana | LABORATOIRE INNOTECH INTERNATIONAL | expired | Sept 2026 |
| Phlebodia Tablets Tablet | 🇳🇬Nigeria | Phillips Pharmaceuticals (Nigeria) Limited | active | Feb 2026 |
| Pilicon Diosmin Tablet Tablet | 🇳🇬Nigeria | Therapeutic Lab. (Nigeria) Limited | active | Jan 2026 |
DIOSMIN in Africa — Regulatory Overview
DIOSMIN is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.